Search:

Home Index Back issues Contact

This item requires a subscription.

NICE guidelines will improve the diagnosis and treatment of lung cancer
LCIP, Volume 2, Number 1.

The National Institute for Health and Clinical Excellence (NICE) and the National Collaborating Centre for Acute Care (NCC-AC) issued guidance for the NHS in England and Wales for the diagnosis and treatment of lung cancer in February 2005.1 This guideline also updates the NICE technology appraisal guidance No. 26 on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer (NSCLC), first published in 2001.2

To view this item, select one of the options below:

Purchase access

In order to view articles you will need to pay a subscription for either 24-hour or annual access. You can view all articles on this site during the subscription period.
Please click here to subscribe.
 

Sign in

If you are already have a subscription, please sign in here.

email address

Password

Forgotten your password?

Important

All the articles are in PDF format.

To view the articles you will need Adobe Acrobat Reader.

To download a copy, free of charge,
please click here.

 
Help
  If you need help accessing this site, please click here.

 


The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsors, publisher, Editor or Editorial Board. Accordingly the sponsors, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.
Copyright (©) 2010 Hayward Group Ltd. The title Lung Cancer in Practice is the property of Hayward Group Ltd and, together with the content, is bound by copyright. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk